This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

JAMA. 2001;286:527.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The FDA has approved the PercuSurge GuardWire Plus Temporary Occlusion and Aspiration System (PercuSurge Inc, Sunnyvale, Calif), for procedures on diseased coronary artery bypass grafts. The device is indicated for use in coronary saphenous vein bypass grafts to contain and aspirate embolic material while performing percutaneous transluminal coronary angioplasty or stenting procedures.

The device consists of a catheter with a distal elastomeric occlusion balloon, an introducer sheath, an adapter for controlling inflation and deflation of the balloon, and an inflator that delivers a controlled volume of diluted contrast media to inflate the balloon. The inflator contains a syringe for catheter preparation and balloon deflation. The syringe also serves as a reservoir for contrast solution.

The device was approved on the basis of the results of a randomized clinical trial of 801 patients who were consecutively enrolled at 70 US sites. All participants had evidence of ischemia and lesions within a . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?